The bill s164-117 would require the FDA to expand education programs for healthcare providers on biological products and biosimilars in the Pharmaceuticals & Biotech industry. Senator Margaret Wood Hassan (D-NH) introduced this bill. Pharmaceuticals & Biotech represents 2.6% of Hassan's identifiable donor base ($0.44M), ranking 58th among donor industries for Democratic senators.

FOLLOW THE TRAIL
How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated June 13, 2026 · internal signal score 45/100.